Sustainability is our business approach at UCB. Our goal is to contribute to the transition toward a low-carbon and green economy to protect the planet by developing and producing medicines for people with severe diseases in the most environmentally sustainable way possible. This means reducing our carbon footprint, water consumption, and waste production across the company. This Earth Day, we are highlighting how we’ve progressed in our goal to reduce our local and global environmental impact by 2030, despite the unprecedented events of 2020.

At UCB, we know that fostering a strong employee culture and a rewarding work environment is critical to continuing to innovate for patients living with severe immunological and neurological conditions. Over the past year, the future of where and how we work and collaborate has been put to the test by COVID-19. Read more from Head of U.S. Corporate Affairs, Patty Fritz, on how UCB is reimagining the workplace at our U.S. Headquarters in Atlanta, Georgia.

With more than 20 years of experience in caring for people living with epilepsy, our goal has always been to know and understand the day-to-day experiences of people living with the disease better than anyone. Over the past year this has been especially true, and the challenges we’ve faced have reinvigorated our commitment to the overall emotional and physical well-being of patients. Read more from UCB’s Head of U.S. Neurology, Mike Davis, about how UCB is finding new ways to better connect with patients and improve their day-to-day experience.

Today, across the globe, people are being impacted by COVID-19, causing not only illness, but also uncertainty and fear. With April being Parkinson’s Awareness month, we're sharing the inspirational stories of PD Warriors who are breaking barriers despite their diagnosis to spread a little positivity during this challenging time. These warriors recently shared their stories with More Than Motion, UCB’s community dedicated to raising awareness of the realities of living with Parkinson's disease (PD), and we're honored to feature them this month.

Each year We Work For Health (WWFH) names a group of select members from across the biopharmaceutical industry Employee Champions. UCB’s Miguel Camargo was named a 2020 WWFH Employee Champion for his dedication to the industry, his teams, and patients. 

UCB is committed to creating an optimal individual experience by caring about and valuing our employees – just as we do for the patients we serve. We believe our people are our greatest strength as an organization and prioritize creating a work environment that encourages all to excel. We are proud to be recognized as a 2021 Top Workplace by the Atlanta Journal-Constitution. Hear more from Armelle Blanchet, U.S. Talent Partner Lead, as she highlights UCB’s well-grounded culture and unwavering commitment to employees. 

As part of our Digital Business Transformation, UCB teams participated in a hackathon to improve the quality and efficiency of clinical study design and data analysis, ultimately a win for the patients we serve. Winners to be announced soon.

On International Women’s Day our Chief Medical Officer, Iris Loew-Friedrich, challenges leaders to step away from perfectionism in order to drive important progress towards equity.